The findings of the aforementioned study highlight that MAGE, GMV and SD reach higher levels in women with insulin-treated GDM than in women with diet therapy-treated GDM during the second trimester, and it is in this period that GMV and HBGI values predict and are correlated with asymmetric macrosomia. This evidence concerns the gene INS and gestational diabetes.